This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rader, D. J. Articles by Puré, E. Search for Related Content PubMed PubMed Citation Articles by Rader, D. J. Articles by Puré, E. Related Collections Genetics of cardiovascular disease Lipid and lipoprotein metabolism Mechanism of atherosclerosis/growth factors

(Circulation Research. 2000;86:1013.)
© 2000 American Heart Association, Inc.

Editorials

Genetic Susceptibility to Atherosclerosis

Insights From Mice

Daniel J. Rader, Ellen Puré

From the Department of Medicine (D.J.R.), University of Pennsylvania School of Medicine, and Wistar Institute (E.P.), Philadelphia, Pa, and Ludwig Institute for Cancer Research (E.P.), New York, NY.

Correspondence to Dr Daniel J. Rader, University of Pennsylvania Medical Center, 614 BRBII/III, 421 Curie Blvd, Philadelphia, PA 19104. E-mail rader@mail.med.upenn.edu

Key Words: atherosclerosis • genetics • lipids • inflammation

	Introduction

 
Atherosclerotic cardiovascular disease (ASCVD) frequently clusters in families. Although environmental factors such as diet, exercise, and smoking play a role in ASCVD, genetic factors are a major determinant of ASCVD risk. For example, in a study of Swedish twins, males with a dizygotic twin who died of premature coronary heart disease had a 4.3-fold increased risk of also dying from coronary heart disease, and if the twin was monozygotic, this risk increased to 14.9-fold.¹ The genetic risk of ASCVD is conferred in part through known metabolic risk factors such as hypertension, dyslipidemia, and diabetes mellitus. However, these risk factors alone do not account for the entire genetic contribution to risk of ASCVD, and there remains substantial interest in the identification of additional genetic cardiovascular risk factors.

Like humans, mouse strains differ considerably in their genetic predisposition to atherosclerosis.² Most mouse strains are resistant to atherosclerosis even when fed an atherogenic diet; the C3H strain is a prototypical-resistant mouse strain. In contrast, C57BL/6J mice have been extensively studied as the mouse strain that is most susceptible to atherosclerosis when fed an atherogenic high-fat, high-cholesterol, cholic acid–containing diet.³ Initially, the focus on C57BL/6J mice centered on differences in plasma lipid levels, especially reduced HDL cholesterol levels, in response to the atherogenic diet⁴ and attempts to map gene loci linked to the phenotype of low HDL cholesterol.⁵ However, previous studies did not distinguish whether these differences in lipid profiles were restricted to particular dietary challenges or reflect an underlying genetic factor that contributes . . . [Full Text of this Article]

This article has been cited by other articles:

				T. Gulesserian, C. Wenzel, G. Endler, R. Sunder-Plassmann, C. Marsik, C. Mannhalter, N. Iordanova, M. Gyongyosi, J. Wojta, S. Mustafa, et al. Clinical Restenosis after Coronary Stent Implantation Is Associated with the Heme Oxygenase-1 Gene Promoter Polymorphism and the Heme Oxygenase-1 +99G/C Variant Clin. Chem., September 1, 2005; 51(9): 1661 - 1665. [Abstract] [Full Text] [PDF]

				M. Navab, J. A. Berliner, G. Subbanagounder, S. Hama, A. J. Lusis, L. W. Castellani, S. Reddy, D. Shih, W. Shi, A. D. Watson, et al. HDL and the Inflammatory Response Induced by LDL-Derived Oxidized Phospholipids Arterioscler Thromb Vasc Biol, April 1, 2001; 21(4): 481 - 488. [Abstract] [Full Text] [PDF]